Restarting Semaglutide After a Month Away from Treatment

Why a four-week gap changes your restart dose

The titration schedule for semaglutide (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg) exists because the drug's gastrointestinal effects are real and dose-dependent. Slowing gastric emptying and reducing appetite are the mechanisms that drive weight loss, but both produce nausea and gut discomfort when introduced too quickly. Titration lets your system adjust gradually, typically in four-week steps.

After a month without the medicine, that adjustment is no longer intact. The NHS semaglutide patient information is specific on this point: if you miss doses or stop treatment, you should discuss restarting with your prescriber because the previous tolerability you built cannot be assumed to carry over. Clinical practice broadly treats a gap of four weeks as the threshold at which full re-escalation, or at least a meaningful step down, is warranted.

In practical terms, this means your prescriber might restart you at 0.25 mg or 0.5 mg rather than your previous maintenance dose, then re-titrate over the following months. The exact starting point depends on how long you stopped, which dose you had reached, and how well you tolerated the medicine before. There is no universal answer, it is a clinical judgement made with your specific history.

What actually happens to weight and appetite during a break

The STEP 1 trial, published in the New England Journal of Medicine and involving nearly 2,000 adults with obesity, found that participants who stopped semaglutide after 68 weeks regained a significant portion of lost weight over the following year. Appetite and hunger signalling returned towards baseline relatively quickly once the drug was cleared. This is not a character failing; it reflects the biology of appetite regulation, which GLP-1 receptor agonists influence while they are present and active.

A one-month break is shorter than the post-trial withdrawal period studied, but the pharmacological principle holds: semaglutide has a half-life of around one week, so after four weeks the medicine has effectively cleared. Hunger and portion tolerance typically begin returning within days to weeks of stopping. Some people find this happens faster than expected, which is why restarting is a common and entirely reasonable decision.

If you gained some weight during the break, that does not affect your eligibility in principle, but it is exactly the kind of clinical context a prescriber needs to see. For a broader look at what the evidence says about semaglutide's effectiveness, the semaglutide overview at nume covers the full trial picture. You can also read about the Wegovy injection specifically, including how it is licensed and what the dosing journey looks like across treatment.

What to expect when you restart, practically speaking

Restarting will feel similar to starting for the first time. The first few doses at a lower strength can bring a familiar wave of nausea, particularly after meals, and appetite suppression may take a couple of weeks to feel meaningful again. Most people find these symptoms settle within the first fortnight at each dose level, mirroring the initial titration experience.

A few things that tend to help: eating smaller portions and stopping before feeling full, staying well hydrated, avoiding rich or fatty food in the first week back, and taking the injection on a day when you do not have commitments that a rough stomach would disrupt. Your prescriber or the patient information leaflet for your medicine will give you the specifics, this is general context, not a protocol to follow in place of clinical advice.

If you are restarting after a longer gap, guidance differs. A two-month break carries different considerations from a four-week one; you can read about restarting Wegovy after two months for that context. People returning after a longer break often ask similar questions, and the six-month restart guide addresses the more significant gaps. For the specific situation of restarting Wegovy after a one-month break rather than semaglutide generally, the Wegovy one-month restart page covers branded-product specifics.

One practical note: when treatment resumes through nume, your prescription is dispatched the same day it is approved and arrives the next working day with DPD. The pen comes in plain packaging with no branding visible from the outside, so there is nothing to identify what is inside.

Getting a prescription to restart, what the process looks like

Semaglutide for weight management (Wegovy) is a prescription-only medicine. You cannot obtain it legally without a valid prescription from a clinician who has assessed you, this applies to restarts as much as new starts. A prescriber needs to confirm your current BMI and health status, check whether anything has changed since your last prescription, and decide on the appropriate restart dose.

If you are considering the cost side of restarting, the Wegovy pricing page gives an honest picture of what private treatment costs in the UK, including what a legitimate price should include. Any service that offers semaglutide without a clinical assessment is operating outside the law, and the MHRA has reported counterfeit pens in circulation that have caused serious harm.

At nume, a real prescriber (not an automated system) reviews every consultation the same day it is submitted. The weight-loss treatment overview explains how the service works if you want more context before starting. If you are ready to check whether you are eligible to restart, the next step is a free consultation with our clinical team.